Pablo A. Ballesteros (@pabloteros) 's Twitter Profile
Pablo A. Ballesteros

@pabloteros

MD, MSc. Medical Oncologist at Hospital 12 de Octubre.
Asturian in Madrid. Like ≠ endorsement.

ID: 301698128

calendar_today19-05-2011 22:18:11

1,1K Tweet

254 Followers

375 Following

David Olmos (@dolmos77) 's Twitter Profile Photo

1/9 Glad to announce that the #CAPTURE study manuscript has been published today in Annals of Oncology Would you like to learn more about it? Just follow this #tweetorial thread 👇 annalsofoncology.org/article/S0923-…

Pablo A. Ballesteros (@pabloteros) 's Twitter Profile Photo

The day has finally arrived! First phase III trial showing ADCs + IO as one of the future strategies to optimize upfront metastatic cancer treatment. The future begins here!

OncoAlert (@oncoalert) 's Twitter Profile Photo

New guidelines alert🚨 The 2024 EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines for #ProstateCancer offer personalized recommendations for screening, diagnosis, and treatment based on the latest data. Emphasizing risk-adapted approaches and advanced imaging, these guidelines reflect

New guidelines alert🚨
The 2024 EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines for #ProstateCancer offer personalized recommendations for screening, diagnosis, and treatment based on the latest data. 

Emphasizing risk-adapted approaches and advanced imaging, these guidelines reflect
Pablo A. Ballesteros (@pabloteros) 's Twitter Profile Photo

An interesting retrospective analysis shedding light on the impact of corticosteroids in the outcomes of immunotherapy treatments. Nice work by the residents of Oncología Médica Hospital Ramón y Cajal, where I did my training. A pleasure to collaborate in this paper.

Pablo A. Ballesteros (@pabloteros) 's Twitter Profile Photo

Here we are, waiting for our delayed train to start the adventure! ESMO Congress 2024 in Barcelona! ESMO - Eur. Oncology Renfe this is a too prestigious congress to do such a mess today with the Madrid-Barcelona connections!

Here we are, waiting for our delayed train to start the adventure! ESMO Congress 2024 in Barcelona! <a href="/myESMO/">ESMO - Eur. Oncology</a>
<a href="/Renfe/">Renfe</a> this is a too prestigious congress to do such a mess today with the Madrid-Barcelona connections!
Yüksel Ürün (@dryukselurun) 's Twitter Profile Photo

High doses of vitamin C, high doses of vitamin D, ivermectin, and fenbendazole have recently been promoted both domestically and internationally as the “new recipe” for cancer treatment. However, such approaches are nothing more than exploitation of people’s hopes with unproven

Pablo A. Ballesteros (@pabloteros) 's Twitter Profile Photo

I'm thrilled to share our latest article in Annals of Oncology which we developed during my time in the MD Anderson Cancer Center It's been an honor to collaborate with these titans of oncology, mentors and friends, as Mohamed A Gouda Ignacio Garrido-Laguna and Jordi Rodon.

Pablo A. Ballesteros (@pabloteros) 's Twitter Profile Photo

Great time in Amsterdam for the IKCS Europe 2025 IKCC Kidney Cancer with the amazing Guillermo de Velasco Glad to share our latest lab results highlighting biomarkers of response to cabozantinib treatment Daniel Castellano

Great time in Amsterdam for the IKCS Europe 2025 <a href="/IKCCorg/">IKCC Kidney Cancer</a> with the amazing <a href="/g_develasco/">Guillermo de Velasco</a> 

Glad to share our latest lab results highlighting biomarkers of response to cabozantinib treatment <a href="/cdanicas/">Daniel Castellano</a>
Vive con Propósito. (@propositoyvida) 's Twitter Profile Photo

3 años - Mamá, te quiero. 10 años - Mamá, no te soporto. 16 años - Mi madre es muy fastidiosa. 18 años - Me voy de esta casa. 25 años - Mamá, tenías razón. 30 años - Quiero ir a casa de mamá. 50 años - No quiero perder a mi madre. 70 años - Dejaría todo por tener a mi mamá

Guillermo de Velasco (@g_develasco) 's Twitter Profile Photo

🚨 When EV/pembro is not an option, what's the best first-line strategy for cisplatin-ineligible patients with advanced urothelial carcinoma? 🧪 The SOGUG-AUREA study evaluated split-dose cisplatin + atezolizumab in this setting 📄 doi.org/10.1200/OA-25-…

Yüksel Ürün (@dryukselurun) 's Twitter Profile Photo

We don’t just treat cancer. We protect dreams, families, and futures. Cancer care is not a privilege, it’s a basic human right. #cancer #oncology

Míticu Oviedo (@miticuroviedo) 's Twitter Profile Photo

En mi opinión, el ovetense más ilustre no es Fernando Alonso ni la Reina Leticia. El más ilustre es el poeta Ángel González. Hoy se cumplen 100 de su nacimiento en Oviedo. Creo que tendría que haberse conmemorado esa fecha mucho más que con 4 actos que parecen de compromiso. 🧵1️⃣

En mi opinión, el ovetense más ilustre no es Fernando Alonso ni la Reina Leticia. El más ilustre es el poeta Ángel González. Hoy se cumplen 100 de su nacimiento en Oviedo. Creo que tendría que haberse conmemorado esa fecha mucho más que con 4 actos que parecen de compromiso. 🧵1️⃣
Pablo A. Ballesteros (@pabloteros) 's Twitter Profile Photo

Ending the ESMO Congress 2025! Amazing days in Berlin with friends. A pleasure to present our work in the GU poster session with resistance signals to QT+IO treatment in urothelial carcinoma transcriptomics and consistent RWD in CPRCm treated with Ra223 Guillermo de Velasco Daniel Castellano

Ending the ESMO Congress 2025! Amazing days in Berlin with friends. A pleasure to present our work in the GU poster session with resistance signals to QT+IO treatment in urothelial carcinoma transcriptomics and consistent RWD in CPRCm treated with Ra223  <a href="/g_develasco/">Guillermo de Velasco</a>  <a href="/cdanicas/">Daniel Castellano</a>